Vertigo Treatment Market Trends, Key Players, DROT, Analysis & Forecast Till 2027
According to MRFR analysis, Vertigo Treatment Market is expected to register a CAGR of 4.2% during the forecast period and accounts for USD 1,800 million in 2018.
Vertigo
refers to a sense of spinning dizziness that can be caused by problems in the
brain or inner ear, including sudden head movements, or inflammation in the
inner ear due to a viral or bacterial infection. Vertigo can be treated with
medications such as steroids that can reduce internal ear inflammation, and
water pills that can reduce fluid buildup in the ear.
The growth
of the global vertigo treatment market is driven by various factors such as an
increase in the prevalence of vertigo, increasing geriatric population, and
rising government initiatives to create awareness of the market. However, lack
of knowledge about the vertigo
symptoms and causes of is projected to hamper the growth of the global
vertigo treatment market.
The global
vertigo treatment market is currently dominated by several market players.
Additionally, growing initiatives to create awareness is driving the growth of
the market. For instance, the German Center for Vertigo and Balance Disorders
(DSGZ) started an initiative to establish a European Network for Vertigo and
Balance Research called DIZZYNET.
Segmentation
The global
vertigo treatment market has been segmented based on type, treatment, and end
user.
The market,
based on type, has been divided into benign paroxysmal positional vertigo
(BPPV), labyrinthitis, vestibular neuronitis, and Meniere’s disease.
The benign
paroxysmal positional vertigo (BPPV) segment is likely to be the largest during
the review period, as is the most common form of peripheral vertigo. The
Meniere’s disease segment is predicted to be the fastest-growing segment as it
is often severe that it causes nausea and vomiting.
The global
vertigo treatment market has been segmented, on the basis of treatment, into
anticholinergics, antihistamines, benzodiazepines, and others. The
anticholinergics segment is expected to hold the majority share of the market
as they are vestibular suppressants and are most important in treating vertigo
since these drugs do not cross the blood-brain barrier. The Benzodiazepines
segment is expected to be the fastest growing as they are useful in controlling
motion sickness and can also minimize anxiety and panic associated with
vertigo.
In terms of
end user, the global vertigo treatment market has been segmented into hospitals
and clinics. Hospitals take up the largest share. The positive growth of
hospitals is attributed to their rising need to offer treatments to various
health disorders. Additionally, the growing rate of hospitals is also driving
the growth for the hospitals segment.
Key
Players
Some of the
key players in the Global Vertigo Treatment Market are F. Hoffmann-La Roche (Switzerland),
GlaxoSmithKline (UK), Novartis (Switzerland), Pfizer (US), Teva Pharmaceutical
(Israel), Sanofi (France), AstraZeneca (UK), Intas Pharmaceutical Ltd (India),
and Sun Pharmaceutical Industries Ltd (India).
Regional
Analysis
The market
has been divided, by region, into the Americas, Europe, Asia-Pacific, and the
Middle East & Africa. The Americas is expected to be the largest market
owing to the rising per capita healthcare expenditure. The vertigo treatment
market in the Americas has further been branched into North America and Latin
America, with the North American market divided into the US and Canada. The
European vertigo treatment market has been categorized as Western Europe and
Eastern Europe. The Western European market has further been classified as
Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The
vertigo treatment market in Asia-Pacific has been segmented into Japan, China,
India, South Korea, Australia, and the rest of Asia-Pacific. Due to the
increasing prevalence of dizziness and vertigo and increasing patient pool, the
market in Asia-Pacific is expected to be the fastest-growing. The vertigo
treatment market in the Middle East & Africa has been bifurcated into the
Middle East and Africa.
About
Market Research Future:
At Market
Research Future (MRFR), we enable our customers to unravel the complexity of
various industries through our Cooked Research Report (CRR), Half-Cooked
Research Reports (HCRR), & Consulting Services. MRFR team have supreme
objective to provide the optimum quality market research and intelligence
services to our clients.
Contact
us:
Market
Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson
Street, 5Th Floor,
New York,
New York 10013
United
States of America
+1 628 258
0071
Email: sales@marketresearchfuture.com
Comments
Post a Comment